Emergent Biosolutions
(EBS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,900 | 82,600 | 48,652 | 15,101 | 10,485 |
| Depreciation Amortization | 12,400 | 44,300 | 29,899 | 20,097 | 10,166 |
| Income taxes - deferred | -4,500 | 3,300 | 18,618 | 4,951 | 4,299 |
| Accounts receivable | 21,800 | -4,800 | 9,411 | 36,160 | 10,561 |
| Accounts payable and accrued liabilities | 3,600 | 16,100 | 2,965 | 4,245 | 81 |
| Other Working Capital | -12,400 | 53,700 | 19,587 | 46,609 | 12,150 |
| Other Operating Activity | -17,000 | 12,900 | 1,482 | -31,490 | -6,071 |
| Operating Cash Flow | $-1,000 | $208,100 | $130,614 | $95,673 | $41,671 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -11,600 | -54,800 | -42,381 | -29,605 | -20,304 |
| Net Acquisitions | N/A | -195,100 | N/A | N/A | N/A |
| Investing Cash Flow | $-11,600 | $-249,900 | $-42,381 | $-29,605 | $-20,304 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,700 | 19,300 | 10,799 | 4,605 | 2,957 |
| Common Stock Repurchased | -100 | -33,100 | -83 | -83 | -81 |
| Other Financing Activity | -6,700 | -37,600 | -29,397 | -26,464 | -25,583 |
| Financing Cash Flow | $-2,100 | $-51,400 | $-18,681 | $-21,942 | $-22,707 |
| Exchange Rate Effect | N/A | N/A | -74 | -12 | -3 |
| Beginning Cash Position | 179,300 | 272,500 | 271,513 | 271,513 | 271,513 |
| End Cash Position | 164,600 | 179,300 | 340,991 | 315,627 | 270,170 |
| Net Cash Flow | $-14,700 | $-93,200 | $69,478 | $44,114 | $-1,343 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,000 | 208,100 | 130,614 | 95,673 | 41,671 |
| Capital Expenditure | -11,600 | -54,800 | -42,381 | -29,605 | -20,304 |
| Free Cash Flow | -12,600 | 153,300 | 88,233 | 66,068 | 21,367 |